Getting more FDA inspectors in China on Hamburg's agenda for trip to China November 17, 2014 | By Eric Palmer

China produces more of the active ingredients that go into global meds than any other country, but its oversight of the burgeoning business has often fallen short. For nearly two years, efforts by the FDA to expand its own oversight in the country have been thwarted, an issue FDA Commissioner Margaret Hamburg hopes to resolve during a visit there this week to meet with Chinese and other global regulators.
more